Jack Reynolds, DVM, DACLAM, DACVP, FIATP

Technical Consultant, Drug Safety Science

Dr. Reynolds brings strong leadership experience in toxicology, safety sciences and drug development gained over a 35-year career in the pharmaceutical industry, most recently as Senior Vice President of R&D and Worldwide Head of Safety Sciences at Pfizer. Dr. Reynolds is a seasoned leader within the pharmaceutical industry having made substantial contributions to numerous development programs and important drug approvals including Lyrica, Celebrex, Exubera, Afrezza and many others. Dr. Reynolds has an extensive track record of building partnerships with regulatory agencies, and through leadership roles in professional societies, industry executive groups and scientific organizations. Dr. Reynolds is the founder and former Advisory Board Chair of the Drug Safety Executive Council, which now includes a membership of almost 2000 industry professionals and plays an important cross-industry role in collaboratively evaluating, validating and qualifying new technologies for safety testing and decision making. He is board certified in both Veterinary Pathology and Laboratory Animal Medicine and is a Fellow of the International Academy of Toxicologic Pathologists.